The role of the hematological inflammatory index and systemic immuno-inflammation index in acute cholecystitis

Authors

DOI:

https://doi.org/10.15584/ejcem.2022.3.11

Keywords:

acute cholecystitis, neutrophil, lymphocyte, platelet, mortality

Abstract

Introduction and aim. Acute cholecystitis is one of the most common hepatobiliary emergencies. We aimed to investigate the role of the initial hematological inflammatory index and systemic immuno-inflammation index in predicting short-term mortality in patients with acute cholecystitis.

Material and methods. This study with a retrospective observational design was conducted at the emergency department of a tertiary teaching hospital. Patients admitted to our clinic between June 15, 2021, and March 15, 2022, according to the Tokyo criteria were included in the sample. The hematological inflammatory index and systemic immuno-inflammation index were calculated using the hematological test results of the patients evaluated at the emergency department. Survivor and non-survivor groups were formed according to all-cause 30-day mortality. The differences between survivor and non-survivor groups were investigated.

Results. A total of 194 patients were included in the final analysis. The median age of the study population was 59 (25th–75th percentiles: 46.75–72) years. The rate of all cause-short-term mortality was 7.7. There were significant differences between the survivor and non-survivor groups in terms of the neutrophil count and the systemic immuno-inflammation index (p=0.007, 0.034, respectively; Mann-Whitney U test). No significant difference was found in the remaining laboratory parameters (lymphocyte count, platelet count, and hematological inflammatory index) (p=0.220, 0.489, 0.367 respectively; Mann-Whitney U test).

Conclusion. The systemic immuno-inflammation index was determined to be significantly higher in the non-survivor group than in the survivor group among the patients with acute cholecystitis. However, there was no significant difference between these two groups in relation to the hematological inflammatory index.

Downloads

Download data is not yet available.

References

Gallaher JR, Charles A. Acute Cholecystitis: A Review. JAMA. 2022;327(10):965‒975.

Lam R, Zakko A, Petrov JC, Kumar P, Duffy AJ, Muniraj T. Gallbladder Disorders: A Comprehensive Review. Dis Mon. 2021;67(7):101130.

Yokoe M, Hata J, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018;25(1):41‒54.

Ozdemir S, Ozkan A. Acute Phase Response. Eurasian Journal of Critical Care. 2021;3(3):81.

Ozkan A. Ideal predictor studies. J Exp Clin Med. 2022;39(2):595‒596.

Walzik D, Joisten N, Zacher J, Zimmer P. Transferring clinically established immune inflammation markers into exercise physiology: focus on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immune-inflammation index. Eur J Appl Physiol. 2021;121(7):1803‒1814.

Sahinli H, Türker S. The hematologic inflammatory index is a new prognostic marker in patients resected for gastric cancer. J Cancer Res Ther. 2020;16:S144‒S149.

DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837‒845.

Ozdemir S, Algın A. Interpretation of the Area Under the Receiver Operating Characteristic Curve. Experimental and Applied Medical Science. 2022;3(1);310‒311.

Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol. 2004;172(5):2731‒2738.

Naidu K, Beenen E, Gananadha S, Mosse C. The Yield of Fever, Inflammatory Markers and Ultrasound in the Diagnosis of Acute Cholecystitis: A Validation of the 2013 Tokyo Guidelines. World J Surg. 2016;40(12):2892‒2897.

Sato N, Kinoshita A, Imai N, et al. Inflammation-based prognostic scores predict disease severity in patients with acute cholecystitis. Eur J Gastroenterol Hepatol. 2018;30(4):484‒489.

Chandrashekara S, Mukhtar Ahmad M, Renuka P, Anupama KR, Renuka K. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis. Int J Rheum Dis. 2017;20(10):1457‒1467.

Mahmood F, Akingboye A, Malam Y, Thakkar M, Jambulingam P. Complicated Acute Cholecystitis: The Role of C-Reactive Protein and Neutrophil-Lymphocyte Ratio as Predictive Markers of Severity. Cureus. 2021;13(2):e13592.

Ertok İ, Karakayalı O, Kocasaban DU. Akut Kolesistit-Kolelitiazis Ayırıcı Tanısında Nötrofil/Lenfosit Oranının Klinik Önemi. Kocaeli Medical J. 2016;5(3):6‒11.

Ozdemir S, Algın A. The Role of Platelet Indices in Predicting Short-Term Mortality in Elderly Patients with Pulmonary Embolism. J Contemp Med. 2021;11(6): 833‒837.

Sayit AT, Gunbey PH, Terzi Y. Is the Mean Platelet Volume in Patients with Acute Cholecystitis an Inflammatory Marker? J Clin Diagn Res. 2015;9(6):TC05‒TC07.

Woo SH, Lee WJ, Seol SH, Kim DH, Choi SP. The accuracies of abdominal computed tomography and the neutrophil-to-lymphocyte ratio used to predict the development of clinically severe acute cholecystitis in elderly patients visiting an emergency department. Niger J Clin Pract. 2018;21(5):645‒652.

Kubota K, Ito R, Narita N, et al. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment. BMC Cancer. 2022;22(1):368.

Öcal L, Keskin M, Cerşit S, et al. Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction. Coron Artery Dis. 2022;33(4):251‒260.

Zhang F, Niu M, Wang L, et al. Systemic-Immune-Inflammation Index as a Promising Biomarker for Predicting Perioperative Ischemic Stroke in Older Patients Who Underwent Non-cardiac Surgery. Front. Aging Neurosci. 2022;14:865244.

Sahinli H, Türker S. The hematologic inflammatory index is a new prognostic marker in patients resected for gastric cancer. J Cancer Res Ther. 2020;16:S144‒S149.

Downloads

Published

2022-09-30

How to Cite

Özdemir, S., Altunok, İbrahim, Özkan, A., İslam, M. M., Algın, A., Eroğlu, S. E., & Aksel, G. (2022). The role of the hematological inflammatory index and systemic immuno-inflammation index in acute cholecystitis. European Journal of Clinical and Experimental Medicine, 20(3), 330–335. https://doi.org/10.15584/ejcem.2022.3.11

Issue

Vol. 20 No. 3 (2022)

Section

ORIGINAL PAPERS

License

Copyright (c) 2022 European Journal of Clinical and Experimental Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.